On October 29, 2026, HHS published proposed revisions to the Mandatory Guidelines for urine testing. The proposal would clarify which types of laboratories may be certified, change invalid specimen criteria, publish the Authorized Drug Testing Panels only when revised instead of each year, and revise initial test quality control requirements. It would also let an MRO authorize a biomarker test in some invalid result cases. These are proposals, and HHS set a comment deadline of December 28, 2026.
Ready to get started?